ScholarIQanswers from OpenAlex

Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding

PaperCitations, authors & open-access status

Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding have?

ScholarIQcitation count

Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding has 133 citations in the OpenAlex counts ScholarIQ stores.

When was Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding published?

ScholarIQyear

Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding has 2013 year in the ScholarIQ index.

What is the open-access status of Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding?

ScholarIQoa status

Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding has closed oa status in the ScholarIQ index.

What is the DOI of Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding?

ScholarIQdoi

The DOI for Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding is on the source record.

What is the PMID of Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding?

ScholarIQpmid

The PMID for Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding is on the source record.

What is the OpenAlex record for Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding?

ScholarIQopenalex

The OpenAlex for Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial